Meaning
Standardized biological assays utilize bacterial reverse mutation systems to identify substances that induce genetic point mutations. Manufacturers of food-contact plastics use the ames test oecd 471 to screen starting monomers, additives, and breakdown products for genotoxic potential.
Mutagenic Screen
Specific strains of Salmonella typhimurium and Escherichia coli are exposed to the test substance both in the presence and absence of an exogenous metabolic activation system derived from rodent liver. Under this protocol, the ames test oecd 471 detects mutations that restore the functional capability of these bacteria to synthesize essential amino acids. High-throughput chemical screening relies on this result to eliminate mutagenic candidates before investing in pilot-scale polymer production.
Protocol Requirement
Specific requirements demand the testing of at least five distinct bacterial strains to cover diverse mutational mechanisms. Each run of the ames test oecd 471 incorporates negative controls and positive controls to validate the sensitivity of the assay. Replicate plating ensures that sporadic background mutations do not obscure the true response of the compound.
Polymer Application
Extractable studies on finished plastic packaging deploy these bacterial assays when uncharacterized non-intentionally added substances emerge during migration tests. If a migrate yields a positive response in the ames test oecd 471, the material requires further downstream genotoxicity testing or must be reformulated to prevent human dietary exposure. Polymer compounders rely on these test results to clear raw materials for high-purity medical or food packaging applications.
This regulatory step prevents toxic chemicals from entering the consumer value chain through recycled polymers.